Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US Adults.

Saved in:
Bibliographic Details
Title: Cost-Effectiveness of Semaglutide for Secondary Prevention of Cardiovascular Disease in US Adults.
Authors: Hennessy S; Department of Epidemiology and Biostatistics, University of California, San Francisco., Penko J; Department of Epidemiology and Biostatistics, University of California, San Francisco., Bellows BK; College of Physicians and Surgeons, Columbia University, New York, New York., Coxson PG; Department of Epidemiology and Biostatistics, University of California, San Francisco., Boylan R; Department of Epidemiology and Biostatistics, University of California, San Francisco., Sims KD; Department of Epidemiology and Biostatistics, University of California, San Francisco.; Boston University School of Public Health, Boston, Massachusetts., Beatty A; Department of Epidemiology and Biostatistics, University of California, San Francisco.; Division of Cardiology, Department of Medicine, University of California, San Francisco., Inoue K; Richard A. and Susan F. Smith Center for Outcomes Research, Boston, Massachusetts.; Department of Social Epidemiology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Shi I; Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Decker SRR; Richard A. and Susan F. Smith Center for Outcomes Research, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Internal Medicine Department, Moinhos de Vento Hospital, Brazil., Khan SS; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Yeh RW; Richard A. and Susan F. Smith Center for Outcomes Research, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Moran AE; College of Physicians and Surgeons, Columbia University, New York, New York., Kazi DS; Richard A. and Susan F. Smith Center for Outcomes Research, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Source: JAMA cardiology [JAMA Cardiol] 2026 Mar 01; Vol. 11 (3), pp. 229-238.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101676033 Publication Model: Print Cited Medium: Internet ISSN: 2380-6591 (Electronic) NLM ISO Abbreviation: JAMA Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2380-6591
DOI:10.1001/jamacardio.2025.5243